Epithelial-Mesenchymal Transition, human (Scheel, 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFATC2
|
ENSG00000101096.15 | NFATC2 |
NFATC3
|
ENSG00000072736.14 | NFATC3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NFATC2 | hg19_v2_chr20_-_50179368_50179392 | -0.62 | 9.8e-02 | Click! |
NFATC3 | hg19_v2_chr16_+_68119764_68119868 | 0.49 | 2.2e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_209602771 | 3.09 |
ENST00000440276.1 |
MIR205HG |
MIR205 host gene (non-protein coding) |
chr1_+_209602609 | 2.56 |
ENST00000458250.1 |
MIR205HG |
MIR205 host gene (non-protein coding) |
chr18_+_29027696 | 2.48 |
ENST00000257189.4 |
DSG3 |
desmoglein 3 |
chr15_+_43885252 | 2.04 |
ENST00000453782.1 ENST00000300283.6 ENST00000437924.1 ENST00000450086.2 |
CKMT1B |
creatine kinase, mitochondrial 1B |
chr15_+_43985084 | 1.98 |
ENST00000434505.1 ENST00000411750.1 |
CKMT1A |
creatine kinase, mitochondrial 1A |
chr5_+_140186647 | 1.81 |
ENST00000512229.2 ENST00000356878.4 ENST00000530339.1 |
PCDHA4 |
protocadherin alpha 4 |
chr5_+_140254884 | 1.81 |
ENST00000398631.2 |
PCDHA12 |
protocadherin alpha 12 |
chr7_-_41742697 | 1.69 |
ENST00000242208.4 |
INHBA |
inhibin, beta A |
chr6_-_136788001 | 1.52 |
ENST00000544465.1 |
MAP7 |
microtubule-associated protein 7 |
chr1_+_44401479 | 1.48 |
ENST00000438616.3 |
ARTN |
artemin |
chr5_+_140220769 | 1.45 |
ENST00000531613.1 ENST00000378123.3 |
PCDHA8 |
protocadherin alpha 8 |
chr6_+_150464155 | 1.32 |
ENST00000361131.4 |
PPP1R14C |
protein phosphatase 1, regulatory (inhibitor) subunit 14C |
chr2_-_216003127 | 1.30 |
ENST00000412081.1 ENST00000272895.7 |
ABCA12 |
ATP-binding cassette, sub-family A (ABC1), member 12 |
chr4_-_11431389 | 1.30 |
ENST00000002596.5 |
HS3ST1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 1 |
chr1_+_46640750 | 1.22 |
ENST00000372003.1 |
TSPAN1 |
tetraspanin 1 |
chr5_+_140207536 | 1.18 |
ENST00000529310.1 ENST00000527624.1 |
PCDHA6 |
protocadherin alpha 6 |
chr5_+_140248518 | 1.16 |
ENST00000398640.2 |
PCDHA11 |
protocadherin alpha 11 |
chr14_+_65171315 | 1.16 |
ENST00000394691.1 |
PLEKHG3 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
chr5_+_140261703 | 1.10 |
ENST00000409494.1 ENST00000289272.2 |
PCDHA13 |
protocadherin alpha 13 |
chr18_-_47376197 | 1.08 |
ENST00000592688.1 |
MYO5B |
myosin VB |
chr5_+_140213815 | 1.08 |
ENST00000525929.1 ENST00000378125.3 |
PCDHA7 |
protocadherin alpha 7 |
chr11_+_128563652 | 1.05 |
ENST00000527786.2 |
FLI1 |
Fli-1 proto-oncogene, ETS transcription factor |
chr18_-_24129367 | 1.04 |
ENST00000408011.3 |
KCTD1 |
potassium channel tetramerization domain containing 1 |
chr3_-_56809685 | 1.04 |
ENST00000413728.2 |
ARHGEF3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
chr20_+_58179582 | 1.00 |
ENST00000371015.1 ENST00000395639.4 |
PHACTR3 |
phosphatase and actin regulator 3 |
chr5_+_66124590 | 0.99 |
ENST00000490016.2 ENST00000403666.1 ENST00000450827.1 |
MAST4 |
microtubule associated serine/threonine kinase family member 4 |
chr10_-_116444371 | 0.93 |
ENST00000533213.2 ENST00000369252.4 |
ABLIM1 |
actin binding LIM protein 1 |
chrX_-_15683147 | 0.93 |
ENST00000380342.3 |
TMEM27 |
transmembrane protein 27 |
chr11_-_72492878 | 0.90 |
ENST00000535054.1 ENST00000545082.1 |
STARD10 |
StAR-related lipid transfer (START) domain containing 10 |
chr20_+_44637526 | 0.85 |
ENST00000372330.3 |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr18_+_61442629 | 0.84 |
ENST00000398019.2 ENST00000540675.1 |
SERPINB7 |
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
chr5_+_167718604 | 0.83 |
ENST00000265293.4 |
WWC1 |
WW and C2 domain containing 1 |
chr11_-_72492903 | 0.80 |
ENST00000537947.1 |
STARD10 |
StAR-related lipid transfer (START) domain containing 10 |
chr18_-_24237339 | 0.80 |
ENST00000580191.1 |
KCTD1 |
potassium channel tetramerization domain containing 1 |
chr1_-_207206092 | 0.79 |
ENST00000359470.5 ENST00000461135.2 |
C1orf116 |
chromosome 1 open reading frame 116 |
chr6_+_106534192 | 0.79 |
ENST00000369091.2 ENST00000369096.4 |
PRDM1 |
PR domain containing 1, with ZNF domain |
chr17_-_56492989 | 0.76 |
ENST00000583753.1 |
RNF43 |
ring finger protein 43 |
chr14_+_65171099 | 0.76 |
ENST00000247226.7 |
PLEKHG3 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
chr6_+_15246501 | 0.74 |
ENST00000341776.2 |
JARID2 |
jumonji, AT rich interactive domain 2 |
chr8_-_95274536 | 0.74 |
ENST00000297596.2 ENST00000396194.2 |
GEM |
GTP binding protein overexpressed in skeletal muscle |
chr6_+_106546808 | 0.71 |
ENST00000369089.3 |
PRDM1 |
PR domain containing 1, with ZNF domain |
chr5_+_140165876 | 0.70 |
ENST00000504120.2 ENST00000394633.3 ENST00000378133.3 |
PCDHA1 |
protocadherin alpha 1 |
chr2_+_198570081 | 0.69 |
ENST00000282276.6 |
MARS2 |
methionyl-tRNA synthetase 2, mitochondrial |
chr14_-_61748550 | 0.69 |
ENST00000555868.1 |
TMEM30B |
transmembrane protein 30B |
chr1_+_44398943 | 0.69 |
ENST00000372359.5 ENST00000414809.3 |
ARTN |
artemin |
chr17_+_16120512 | 0.68 |
ENST00000581006.1 ENST00000584797.1 ENST00000498772.2 ENST00000225609.5 ENST00000395844.4 ENST00000477745.1 |
PIGL |
phosphatidylinositol glycan anchor biosynthesis, class L |
chr8_-_15095832 | 0.68 |
ENST00000382080.1 |
SGCZ |
sarcoglycan, zeta |
chr12_-_50616122 | 0.67 |
ENST00000552823.1 ENST00000552909.1 |
LIMA1 |
LIM domain and actin binding 1 |
chr5_+_140180635 | 0.67 |
ENST00000522353.2 ENST00000532566.2 |
PCDHA3 |
protocadherin alpha 3 |
chr5_-_78808617 | 0.65 |
ENST00000282260.6 ENST00000508576.1 ENST00000535690.1 |
HOMER1 |
homer homolog 1 (Drosophila) |
chrX_+_105937068 | 0.64 |
ENST00000324342.3 |
RNF128 |
ring finger protein 128, E3 ubiquitin protein ligase |
chr15_+_43985725 | 0.63 |
ENST00000413453.2 |
CKMT1A |
creatine kinase, mitochondrial 1A |
chr14_-_23623577 | 0.63 |
ENST00000422941.2 ENST00000453702.1 |
SLC7A8 |
solute carrier family 7 (amino acid transporter light chain, L system), member 8 |
chr10_+_47746929 | 0.62 |
ENST00000340243.6 ENST00000374277.5 ENST00000449464.2 ENST00000538825.1 ENST00000335083.5 |
ANXA8L2 AL603965.1 |
annexin A8-like 2 Protein LOC100996760 |
chr4_+_100737954 | 0.59 |
ENST00000296414.7 ENST00000512369.1 |
DAPP1 |
dual adaptor of phosphotyrosine and 3-phosphoinositides |
chr7_-_25702669 | 0.58 |
ENST00000446840.1 |
AC003090.1 |
AC003090.1 |
chr14_+_61789382 | 0.57 |
ENST00000555082.1 |
PRKCH |
protein kinase C, eta |
chr12_-_6484715 | 0.57 |
ENST00000228916.2 |
SCNN1A |
sodium channel, non-voltage-gated 1 alpha subunit |
chr12_-_50616382 | 0.56 |
ENST00000552783.1 |
LIMA1 |
LIM domain and actin binding 1 |
chr8_+_98900132 | 0.54 |
ENST00000520016.1 |
MATN2 |
matrilin 2 |
chr3_+_140981456 | 0.53 |
ENST00000504264.1 |
ACPL2 |
acid phosphatase-like 2 |
chr6_-_11779403 | 0.53 |
ENST00000414691.3 |
ADTRP |
androgen-dependent TFPI-regulating protein |
chr8_+_128748466 | 0.53 |
ENST00000524013.1 ENST00000520751.1 |
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
chr7_-_156803329 | 0.52 |
ENST00000252971.6 |
MNX1 |
motor neuron and pancreas homeobox 1 |
chr1_-_160990886 | 0.52 |
ENST00000537746.1 |
F11R |
F11 receptor |
chr5_+_140201183 | 0.51 |
ENST00000529619.1 ENST00000529859.1 ENST00000378126.3 |
PCDHA5 |
protocadherin alpha 5 |
chr1_+_82266053 | 0.51 |
ENST00000370715.1 ENST00000370713.1 ENST00000319517.6 ENST00000370717.2 ENST00000394879.1 ENST00000271029.4 ENST00000335786.5 |
LPHN2 |
latrophilin 2 |
chr5_+_140174429 | 0.51 |
ENST00000520672.2 ENST00000378132.1 ENST00000526136.1 |
PCDHA2 |
protocadherin alpha 2 |
chr18_+_55888767 | 0.51 |
ENST00000431212.2 ENST00000586268.1 ENST00000587190.1 |
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chr2_-_113594279 | 0.49 |
ENST00000416750.1 ENST00000418817.1 ENST00000263341.2 |
IL1B |
interleukin 1, beta |
chr11_-_88070920 | 0.47 |
ENST00000524463.1 ENST00000227266.5 |
CTSC |
cathepsin C |
chr11_-_88070896 | 0.46 |
ENST00000529974.1 ENST00000527018.1 |
CTSC |
cathepsin C |
chr2_-_165424973 | 0.46 |
ENST00000543549.1 |
GRB14 |
growth factor receptor-bound protein 14 |
chrX_-_133792480 | 0.46 |
ENST00000359237.4 |
PLAC1 |
placenta-specific 1 |
chr6_-_11779840 | 0.45 |
ENST00000506810.1 |
ADTRP |
androgen-dependent TFPI-regulating protein |
chr2_+_162272605 | 0.44 |
ENST00000389554.3 |
TBR1 |
T-box, brain, 1 |
chr17_+_74372662 | 0.43 |
ENST00000591651.1 ENST00000545180.1 |
SPHK1 |
sphingosine kinase 1 |
chr17_-_46657473 | 0.43 |
ENST00000332503.5 |
HOXB4 |
homeobox B4 |
chr15_+_45722727 | 0.43 |
ENST00000396650.2 ENST00000558435.1 ENST00000344300.3 |
C15orf48 |
chromosome 15 open reading frame 48 |
chr18_-_53089723 | 0.43 |
ENST00000561992.1 ENST00000562512.2 |
TCF4 |
transcription factor 4 |
chr2_-_74667612 | 0.42 |
ENST00000305557.5 ENST00000233330.6 |
RTKN |
rhotekin |
chr7_-_71868354 | 0.41 |
ENST00000412588.1 |
CALN1 |
calneuron 1 |
chr17_-_39093672 | 0.41 |
ENST00000209718.3 ENST00000436344.3 ENST00000485751.1 |
KRT23 |
keratin 23 (histone deacetylase inducible) |
chr13_-_86373536 | 0.41 |
ENST00000400286.2 |
SLITRK6 |
SLIT and NTRK-like family, member 6 |
chr6_-_11779174 | 0.40 |
ENST00000379413.2 |
ADTRP |
androgen-dependent TFPI-regulating protein |
chr1_+_156117149 | 0.40 |
ENST00000435124.1 |
SEMA4A |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr7_-_20256965 | 0.40 |
ENST00000400331.5 ENST00000332878.4 |
MACC1 |
metastasis associated in colon cancer 1 |
chr3_+_111718173 | 0.40 |
ENST00000494932.1 |
TAGLN3 |
transgelin 3 |
chr14_+_32546274 | 0.39 |
ENST00000396582.2 |
ARHGAP5 |
Rho GTPase activating protein 5 |
chr12_-_52828147 | 0.39 |
ENST00000252245.5 |
KRT75 |
keratin 75 |
chr19_-_55881741 | 0.39 |
ENST00000264563.2 ENST00000590625.1 ENST00000585513.1 |
IL11 |
interleukin 11 |
chr20_-_14318248 | 0.38 |
ENST00000378053.3 ENST00000341420.4 |
FLRT3 |
fibronectin leucine rich transmembrane protein 3 |
chr12_+_83080659 | 0.38 |
ENST00000321196.3 |
TMTC2 |
transmembrane and tetratricopeptide repeat containing 2 |
chr7_-_121944491 | 0.38 |
ENST00000331178.4 ENST00000427185.2 ENST00000442488.2 |
FEZF1 |
FEZ family zinc finger 1 |
chr15_-_52587945 | 0.38 |
ENST00000443683.2 ENST00000558479.1 ENST00000261839.7 |
MYO5C |
myosin VC |
chr6_-_47010061 | 0.37 |
ENST00000371253.2 |
GPR110 |
G protein-coupled receptor 110 |
chr4_-_153274078 | 0.36 |
ENST00000263981.5 |
FBXW7 |
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr12_-_54779511 | 0.35 |
ENST00000551109.1 ENST00000546970.1 |
ZNF385A |
zinc finger protein 385A |
chr13_-_46716969 | 0.35 |
ENST00000435666.2 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
chr12_-_323689 | 0.35 |
ENST00000428720.1 |
SLC6A12 |
solute carrier family 6 (neurotransmitter transporter), member 12 |
chr8_-_17555164 | 0.34 |
ENST00000297488.6 |
MTUS1 |
microtubule associated tumor suppressor 1 |
chr4_-_72649763 | 0.34 |
ENST00000513476.1 |
GC |
group-specific component (vitamin D binding protein) |
chr4_+_71200681 | 0.34 |
ENST00000273936.5 |
CABS1 |
calcium-binding protein, spermatid-specific 1 |
chr4_-_71532339 | 0.34 |
ENST00000254801.4 |
IGJ |
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr7_+_140373619 | 0.33 |
ENST00000483369.1 |
ADCK2 |
aarF domain containing kinase 2 |
chr1_+_247579451 | 0.33 |
ENST00000391828.3 ENST00000366497.2 |
NLRP3 |
NLR family, pyrin domain containing 3 |
chr18_-_52989217 | 0.33 |
ENST00000570287.2 |
TCF4 |
transcription factor 4 |
chr20_+_55204351 | 0.33 |
ENST00000201031.2 |
TFAP2C |
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) |
chr17_-_39274606 | 0.33 |
ENST00000391413.2 |
KRTAP4-11 |
keratin associated protein 4-11 |
chr18_-_53070913 | 0.33 |
ENST00000568186.1 ENST00000564228.1 |
TCF4 |
transcription factor 4 |
chr10_+_111967345 | 0.32 |
ENST00000332674.5 ENST00000453116.1 |
MXI1 |
MAX interactor 1, dimerization protein |
chr4_-_100356291 | 0.32 |
ENST00000476959.1 ENST00000482593.1 |
ADH7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
chr14_+_32546145 | 0.32 |
ENST00000556611.1 ENST00000539826.2 |
ARHGAP5 |
Rho GTPase activating protein 5 |
chr5_+_135394840 | 0.32 |
ENST00000503087.1 |
TGFBI |
transforming growth factor, beta-induced, 68kDa |
chr13_+_97928395 | 0.32 |
ENST00000445661.2 |
MBNL2 |
muscleblind-like splicing regulator 2 |
chr6_+_43739697 | 0.31 |
ENST00000230480.6 |
VEGFA |
vascular endothelial growth factor A |
chrX_-_117107542 | 0.31 |
ENST00000371878.1 |
KLHL13 |
kelch-like family member 13 |
chr9_+_125376948 | 0.31 |
ENST00000297913.2 |
OR1Q1 |
olfactory receptor, family 1, subfamily Q, member 1 |
chr1_+_24646002 | 0.31 |
ENST00000356046.2 |
GRHL3 |
grainyhead-like 3 (Drosophila) |
chr19_+_41281416 | 0.31 |
ENST00000597140.1 |
MIA |
melanoma inhibitory activity |
chr1_-_156675535 | 0.31 |
ENST00000368221.1 |
CRABP2 |
cellular retinoic acid binding protein 2 |
chr13_+_97874574 | 0.31 |
ENST00000343600.4 ENST00000345429.6 ENST00000376673.3 |
MBNL2 |
muscleblind-like splicing regulator 2 |
chr19_-_49567124 | 0.31 |
ENST00000301411.3 |
NTF4 |
neurotrophin 4 |
chr12_-_71031220 | 0.30 |
ENST00000334414.6 |
PTPRB |
protein tyrosine phosphatase, receptor type, B |
chr3_-_124839648 | 0.30 |
ENST00000430155.2 |
SLC12A8 |
solute carrier family 12, member 8 |
chr12_-_71031185 | 0.30 |
ENST00000548122.1 ENST00000551525.1 ENST00000550358.1 |
PTPRB |
protein tyrosine phosphatase, receptor type, B |
chrX_+_56259316 | 0.30 |
ENST00000468660.1 |
KLF8 |
Kruppel-like factor 8 |
chr17_+_30814707 | 0.30 |
ENST00000584792.1 |
CDK5R1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
chr6_-_13487784 | 0.30 |
ENST00000379287.3 |
GFOD1 |
glucose-fructose oxidoreductase domain containing 1 |
chr17_+_38334242 | 0.30 |
ENST00000436615.3 |
RAPGEFL1 |
Rap guanine nucleotide exchange factor (GEF)-like 1 |
chr9_+_115913222 | 0.29 |
ENST00000259392.3 |
SLC31A2 |
solute carrier family 31 (copper transporter), member 2 |
chr2_+_42104692 | 0.29 |
ENST00000398796.2 ENST00000442214.1 |
AC104654.1 |
AC104654.1 |
chrX_-_117107680 | 0.29 |
ENST00000447671.2 ENST00000262820.3 |
KLHL13 |
kelch-like family member 13 |
chr22_-_39640756 | 0.29 |
ENST00000331163.6 |
PDGFB |
platelet-derived growth factor beta polypeptide |
chr5_-_77844974 | 0.29 |
ENST00000515007.2 |
LHFPL2 |
lipoma HMGIC fusion partner-like 2 |
chr17_-_46688334 | 0.29 |
ENST00000239165.7 |
HOXB7 |
homeobox B7 |
chr4_-_22444733 | 0.28 |
ENST00000508133.1 |
GPR125 |
G protein-coupled receptor 125 |
chr8_+_86121448 | 0.27 |
ENST00000520225.1 |
E2F5 |
E2F transcription factor 5, p130-binding |
chr4_+_69313145 | 0.27 |
ENST00000305363.4 |
TMPRSS11E |
transmembrane protease, serine 11E |
chr12_-_24103954 | 0.27 |
ENST00000441133.2 ENST00000545921.1 |
SOX5 |
SRY (sex determining region Y)-box 5 |
chr19_+_41281282 | 0.27 |
ENST00000263369.3 |
MIA |
melanoma inhibitory activity |
chr10_+_118305435 | 0.27 |
ENST00000369221.2 |
PNLIP |
pancreatic lipase |
chr18_-_52989525 | 0.27 |
ENST00000457482.3 |
TCF4 |
transcription factor 4 |
chr20_+_1875110 | 0.27 |
ENST00000400068.3 |
SIRPA |
signal-regulatory protein alpha |
chr3_-_27763803 | 0.27 |
ENST00000449599.1 |
EOMES |
eomesodermin |
chr18_-_53069419 | 0.27 |
ENST00000570177.2 |
TCF4 |
transcription factor 4 |
chr4_+_155665123 | 0.27 |
ENST00000336356.3 |
LRAT |
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) |
chr1_-_156675368 | 0.26 |
ENST00000368222.3 |
CRABP2 |
cellular retinoic acid binding protein 2 |
chr1_-_183559693 | 0.26 |
ENST00000367535.3 ENST00000413720.1 ENST00000418089.1 |
NCF2 |
neutrophil cytosolic factor 2 |
chr14_-_21562648 | 0.26 |
ENST00000555270.1 |
ZNF219 |
zinc finger protein 219 |
chr3_-_141747950 | 0.26 |
ENST00000497579.1 |
TFDP2 |
transcription factor Dp-2 (E2F dimerization partner 2) |
chr18_-_67872891 | 0.26 |
ENST00000454359.1 ENST00000437017.1 |
RTTN |
rotatin |
chr1_+_100503643 | 0.26 |
ENST00000370152.3 |
HIAT1 |
hippocampus abundant transcript 1 |
chr11_+_55578854 | 0.26 |
ENST00000333973.2 |
OR5L1 |
olfactory receptor, family 5, subfamily L, member 1 |
chr1_+_24645807 | 0.25 |
ENST00000361548.4 |
GRHL3 |
grainyhead-like 3 (Drosophila) |
chr1_-_153538011 | 0.25 |
ENST00000368707.4 |
S100A2 |
S100 calcium binding protein A2 |
chr17_-_74528128 | 0.25 |
ENST00000590175.1 |
CYGB |
cytoglobin |
chr1_+_24645865 | 0.25 |
ENST00000342072.4 |
GRHL3 |
grainyhead-like 3 (Drosophila) |
chr9_-_117692697 | 0.25 |
ENST00000223795.2 |
TNFSF8 |
tumor necrosis factor (ligand) superfamily, member 8 |
chr11_+_34654011 | 0.25 |
ENST00000531794.1 |
EHF |
ets homologous factor |
chr10_+_71561630 | 0.25 |
ENST00000398974.3 ENST00000398971.3 ENST00000398968.3 ENST00000398966.3 ENST00000398964.3 ENST00000398969.3 ENST00000356340.3 ENST00000398972.3 ENST00000398973.3 |
COL13A1 |
collagen, type XIII, alpha 1 |
chr8_+_80523321 | 0.25 |
ENST00000518111.1 |
STMN2 |
stathmin-like 2 |
chr5_+_38845960 | 0.25 |
ENST00000502536.1 |
OSMR |
oncostatin M receptor |
chr18_-_53068911 | 0.25 |
ENST00000537856.3 |
TCF4 |
transcription factor 4 |
chr12_-_109747023 | 0.25 |
ENST00000355216.1 ENST00000299162.5 |
FOXN4 |
forkhead box N4 |
chr18_-_53257027 | 0.25 |
ENST00000568740.1 ENST00000564403.2 ENST00000537578.1 |
TCF4 |
transcription factor 4 |
chr9_+_103204553 | 0.25 |
ENST00000502978.1 ENST00000334943.6 |
MSANTD3-TMEFF1 TMEFF1 |
MSANTD3-TMEFF1 readthrough transmembrane protein with EGF-like and two follistatin-like domains 1 |
chr3_-_27764190 | 0.25 |
ENST00000537516.1 |
EOMES |
eomesodermin |
chr19_+_41281060 | 0.24 |
ENST00000594436.1 ENST00000597784.1 |
MIA |
melanoma inhibitory activity |
chr11_-_57089671 | 0.24 |
ENST00000532437.1 |
TNKS1BP1 |
tankyrase 1 binding protein 1, 182kDa |
chr17_+_55162453 | 0.24 |
ENST00000575322.1 ENST00000337714.3 ENST00000314126.3 |
AKAP1 |
A kinase (PRKA) anchor protein 1 |
chr12_+_11802753 | 0.24 |
ENST00000396373.4 |
ETV6 |
ets variant 6 |
chr17_-_7197881 | 0.24 |
ENST00000007699.5 |
YBX2 |
Y box binding protein 2 |
chr1_-_153521597 | 0.23 |
ENST00000368712.1 |
S100A3 |
S100 calcium binding protein A3 |
chr13_-_41240717 | 0.23 |
ENST00000379561.5 |
FOXO1 |
forkhead box O1 |
chr1_-_41131326 | 0.23 |
ENST00000372684.3 |
RIMS3 |
regulating synaptic membrane exocytosis 3 |
chr17_-_17740325 | 0.23 |
ENST00000338854.5 |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
chr4_-_153303658 | 0.23 |
ENST00000296555.5 |
FBXW7 |
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr11_+_9482551 | 0.23 |
ENST00000438144.2 ENST00000526657.1 ENST00000299606.2 ENST00000534265.1 ENST00000412390.2 |
ZNF143 |
zinc finger protein 143 |
chr3_+_193853927 | 0.23 |
ENST00000232424.3 |
HES1 |
hes family bHLH transcription factor 1 |
chr8_-_17533838 | 0.23 |
ENST00000400046.1 |
MTUS1 |
microtubule associated tumor suppressor 1 |
chr8_-_95449155 | 0.23 |
ENST00000481490.2 |
FSBP |
fibrinogen silencer binding protein |
chr6_-_13487825 | 0.22 |
ENST00000603223.1 |
GFOD1 |
glucose-fructose oxidoreductase domain containing 1 |
chr1_-_226926864 | 0.22 |
ENST00000429204.1 ENST00000366784.1 |
ITPKB |
inositol-trisphosphate 3-kinase B |
chr10_-_105615164 | 0.22 |
ENST00000355946.2 ENST00000369774.4 |
SH3PXD2A |
SH3 and PX domains 2A |
chrY_-_2655644 | 0.22 |
ENST00000525526.2 ENST00000534739.2 ENST00000383070.1 |
SRY |
sex determining region Y |
chr6_-_47009996 | 0.22 |
ENST00000371243.2 |
GPR110 |
G protein-coupled receptor 110 |
chr4_-_123377880 | 0.22 |
ENST00000226730.4 |
IL2 |
interleukin 2 |
chr8_-_91095099 | 0.22 |
ENST00000265431.3 |
CALB1 |
calbindin 1, 28kDa |
chr1_+_145413268 | 0.22 |
ENST00000421822.2 ENST00000336751.5 ENST00000497365.1 ENST00000475797.1 |
HFE2 |
hemochromatosis type 2 (juvenile) |
chr14_+_75536280 | 0.22 |
ENST00000238686.8 |
ZC2HC1C |
zinc finger, C2HC-type containing 1C |
chr1_+_174846570 | 0.22 |
ENST00000392064.2 |
RABGAP1L |
RAB GTPase activating protein 1-like |
chr3_-_184079382 | 0.22 |
ENST00000344937.7 ENST00000423355.2 ENST00000434054.2 ENST00000457512.1 ENST00000265593.4 |
CLCN2 |
chloride channel, voltage-sensitive 2 |
chr8_-_28243590 | 0.21 |
ENST00000523095.1 ENST00000522795.1 |
ZNF395 |
zinc finger protein 395 |
chr19_+_13134772 | 0.21 |
ENST00000587760.1 ENST00000585575.1 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
chr13_+_80055284 | 0.21 |
ENST00000218652.7 |
NDFIP2 |
Nedd4 family interacting protein 2 |
chr11_-_75062829 | 0.21 |
ENST00000393505.4 |
ARRB1 |
arrestin, beta 1 |
chrX_+_105192423 | 0.21 |
ENST00000540278.1 |
NRK |
Nik related kinase |
chr4_-_143226979 | 0.21 |
ENST00000514525.1 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chr13_+_80055581 | 0.21 |
ENST00000487865.1 |
NDFIP2 |
Nedd4 family interacting protein 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.4 | 2.2 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.3 | 1.3 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 1.5 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
0.3 | 2.6 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 0.5 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.2 | 0.7 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.2 | 0.7 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.2 | 0.8 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.2 | 0.7 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.2 | 0.5 | GO:0090094 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
0.2 | 0.5 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.2 | 0.7 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.6 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
0.2 | 0.8 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.4 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.1 | 1.7 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 1.1 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.6 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.1 | 0.4 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
0.1 | 0.3 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.1 | 0.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.3 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.1 | 0.4 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.1 | 0.9 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.4 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.5 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.1 | 0.3 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.1 | 0.2 | GO:2000974 | trochlear nerve development(GO:0021558) auditory receptor cell fate determination(GO:0042668) negative regulation of auditory receptor cell differentiation(GO:0045608) regulation of timing of neuron differentiation(GO:0060164) negative regulation of pro-B cell differentiation(GO:2000974) |
0.1 | 0.9 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.8 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.5 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.1 | 0.3 | GO:0090677 | metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
0.1 | 0.4 | GO:1902162 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.1 | 0.3 | GO:0021622 | optic cup structural organization(GO:0003409) oculomotor nerve development(GO:0021557) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.1 | 0.4 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.1 | 13.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.4 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.4 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.1 | 0.6 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 0.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.6 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.1 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.1 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.6 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.2 | GO:0009386 | translational attenuation(GO:0009386) |
0.1 | 0.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.2 | GO:0070997 | neuron death(GO:0070997) |
0.1 | 0.2 | GO:0050777 | negative regulation of immune response(GO:0050777) |
0.1 | 0.2 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.1 | 0.2 | GO:0043049 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.1 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 1.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.8 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.0 | 0.4 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.0 | 0.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.8 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.0 | 0.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.2 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.2 | GO:0007619 | courtship behavior(GO:0007619) |
0.0 | 0.6 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.3 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.0 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.7 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 0.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.4 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.0 | 0.2 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.0 | 0.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.2 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.2 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.0 | 0.2 | GO:0043553 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.0 | 0.1 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.0 | 0.1 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.0 | 0.1 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.0 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.0 | 0.1 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.0 | 0.1 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.0 | 0.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.0 | 0.3 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.2 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 0.1 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.0 | 0.1 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.0 | 0.7 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.2 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.1 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.0 | 0.2 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.0 | 0.3 | GO:0050890 | cognition(GO:0050890) |
0.0 | 0.1 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
0.0 | 0.2 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.0 | 0.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.1 | GO:0060578 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
0.0 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.1 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.0 | 0.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.2 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.0 | 0.1 | GO:0015862 | uridine transport(GO:0015862) |
0.0 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.3 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.0 | 0.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.7 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.0 | 0.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.2 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.0 | 0.1 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.0 | 0.3 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.9 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 0.1 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.0 | 0.2 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.0 | 0.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.4 | GO:0006023 | aminoglycan biosynthetic process(GO:0006023) glycosaminoglycan biosynthetic process(GO:0006024) |
0.0 | 0.1 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.0 | 0.1 | GO:0070778 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
0.0 | 0.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.2 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.0 | GO:0042704 | uterine wall breakdown(GO:0042704) |
0.0 | 0.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.0 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.0 | 0.1 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.0 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 0.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.0 | 0.1 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.0 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.0 | 0.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.1 | GO:0046479 | ganglioside catabolic process(GO:0006689) glycosphingolipid catabolic process(GO:0046479) |
0.0 | 0.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.1 | GO:0043335 | protein unfolding(GO:0043335) |
0.0 | 0.6 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.0 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
0.0 | 0.0 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.0 | 1.6 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.0 | 0.2 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.1 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.0 | 0.0 | GO:0035989 | tendon development(GO:0035989) |
0.0 | 0.1 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.0 | 0.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.3 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.0 | 0.0 | GO:0035377 | transepithelial water transport(GO:0035377) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.0 | GO:0042495 | detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.0 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.0 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 0.0 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.0 | 0.1 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.3 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.1 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.3 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.0 | 0.0 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.1 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.0 | 0.1 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.8 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.3 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.0 | 0.0 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.0 | 0.2 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.0 | GO:2000909 | negative regulation of cytokine secretion involved in immune response(GO:0002740) regulation of cholesterol import(GO:0060620) negative regulation of cholesterol import(GO:0060621) regulation of sterol import(GO:2000909) negative regulation of sterol import(GO:2000910) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.2 | 1.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 1.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.5 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.1 | 0.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 1.2 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.6 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 2.5 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.2 | GO:1990032 | parallel fiber(GO:1990032) |
0.1 | 0.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.2 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.0 | 0.0 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.6 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.1 | GO:0097679 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) other organism cytoplasm(GO:0097679) |
0.0 | 0.3 | GO:0032010 | phagolysosome(GO:0032010) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.0 | 0.6 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.1 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 0.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.7 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.1 | GO:0098855 | HCN channel complex(GO:0098855) |
0.0 | 0.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.1 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.0 | 0.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.2 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.0 | GO:0031906 | late endosome lumen(GO:0031906) |
0.0 | 0.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.0 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.0 | 0.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.1 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.7 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.0 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.0 | 0.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.0 | 0.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 1.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.3 | GO:0097708 | cytoplasmic vesicle(GO:0031410) intracellular vesicle(GO:0097708) |
0.0 | 0.1 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 1.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.0 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 2.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.0 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.4 | 2.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 1.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 2.2 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 0.7 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.1 | 1.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.9 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.4 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.1 | 0.4 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.1 | 0.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.3 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.1 | 1.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.3 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.1 | 0.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.4 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.1 | 0.3 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.1 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.2 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.1 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.1 | 0.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.2 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.1 | 0.9 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.2 | GO:0032810 | sterol response element binding(GO:0032810) |
0.0 | 0.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.0 | 0.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.0 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.3 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.0 | 0.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 1.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.0 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.2 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.0 | 0.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.0 | 0.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.0 | 0.2 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.0 | 0.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.1 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
0.0 | 1.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.0 | 0.1 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.2 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.0 | 1.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.3 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.6 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.2 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.0 | 0.1 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.0 | 0.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.0 | 0.2 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.0 | 0.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.0 | 0.1 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 0.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.0 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 2.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 1.9 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.0 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.0 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 2.6 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.1 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.0 | 0.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.1 | GO:0001093 | TFIIB-class transcription factor binding(GO:0001093) |
0.0 | 0.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 1.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.2 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 1.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 1.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 2.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 1.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 1.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 1.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.1 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.2 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 3.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |